Business NewsPR NewsWire • Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology

Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology

Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology

SALT LAKE CITY, Dec. 7, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development and beyond through disruptive innovation, today announced a transformational...

View More : https://www.prnewswire.com:443/news-releases/recursion-announces-transformational-collaboration-with-roche-and-genentech...
Releted News by prnewswire
"Recebo muito bem a ideia do "Aspire Fellows Meet Other Sports", disse Arsene Wenger no Aspire Academy Global Summit
Liberty Defense Signs Maryland Stadium Authority, Camden Yards Sports Complex, as a Beta Client
Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology
Vistra Announces New Green Preferred Stock Offering Pursuant to Newly Adopted Green Finance Framework
Toys and Games Market Size to Grow by USD 50.73 Billion | Technavio
Kanazawa University research: First point of attack: Understanding the entry mechanism of SARS-CoV-2 into human cells